The ability of receptor activation to regulate osmosensitive K ϩ fluxes (monitored as 86 Rb ϩ ) in SH-SY5Y neuroblastoma has been examined. Incubation of SH-SY5Y cells in buffers rendered increasingly hypotonic by a reduction in NaCl concentration resulted in an enhanced basal efflux of Rb ϩ (threshold of release, 200 mOsM) but had no effect on Rb ϩ influx. Addition of the muscarinic cholinergic agonist, oxotremorine-M (Oxo-M), potently enhanced Rb ϩ efflux (EC 50 ϭ 0.45 M) and increased the threshold of release to 280 mOsM. Oxo-M elicited a similarly potent, but osmolarity-independent, enhancement of Rb ϩ influx (EC 50 ϭ 1.35 M). However, when incubated under hypotonic conditions in which osmolarity was varied by the addition of sucrose to a fixed concentration of NaCl, basal-and Oxo-M-stimulated Rb ϩ influx and efflux were demonstrated to be dependent upon osmolarity. Basal-and Oxo-M-stimulated Rb ϩ influx (but not Rb ϩ efflux) were inhibited by inclusion of ouabain or furosemide. Both Rb ϩ influx and efflux were inhibited by removal of intracellular Ca 2ϩ and inhibition of protein kinase C activity. In addition to Oxo-M, agonists acting at other cell surface receptors previously implicated in organic osmolyte release enhanced both Rb ϩ efflux and influx under hypotonic conditions. Oxo-M had no effect on cellular K ϩ concentration in SH-SY5Y cells under physiologically relevant reductions in osmolarity (0 -15%) unless K ϩ influx was blocked. Thus, although receptor activation enhances the osmosensitive efflux of K ϩ , it also stimulates K ϩ influx, and the latter permits retention of K ϩ by the cells.
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Regulation of cell volume is of prime importance to the central nervous system (CNS) due to the restricted volume of the skull (Pasantes-Morales et al., 2000 . Even modest alterations in brain cell volume can have profound effects within the CNS because the spatial relationships among neurons, astrocytes, and extracellular space are compromised. Brain cells swell either via changes in plasma osmolarity (hypo-osmotic swelling) or intracellular ion and water distribution (isotonic swelling or cellular/cytotoxic edema). The most prevalent cause of hypo-osmotic swelling is a condition known as hyponatremia, which is defined as a reduction in serum Na ϩ concentration from a normal value of 145 to 136 mM or below. Hyponatremia, which may result from congestive heart failure, nephrotic syndrome, hepatic cirrhosis, inappropriate secretion of antidiuretic hormone, or psychotic polydipsia, occurs in 2.5% of hospitalized patients (Lien and Shapiro, 2007) . It disproportionately affects the young and the elderly and causes predominantly neurological symptoms such as lethargy, confusion, and coma.
After hypo-osmotic stress, cells swell in proportion to the reduction in osmolarity and then normalize their volume in a recovery process known as regulatory volume decrease in which osmolytes (K ϩ , Cl Ϫ , and small organic molecules) are extruded, and cell volume is normalized via the exit of obligated water (McManus et al., 1995) . Inorganic osmolytes, such as K ϩ and Cl Ϫ , constitute the quantitatively major component of the osmolyte pool (60 -70%), whereas organic osmolytes such as taurine, glutamate, and inositol comprise the remainder (Pasantes-Morales et al., 2002) . In most (but not all) tissues, the extrusion of Cl Ϫ and organic osmolytes seems to occur via a common, volume-sensitive organic osmolyte and anion channel, which is primarily permeable to Cl Ϫ but impermeable to cations (Sá nchez-Olea et al., 1996; Lang et al., 1998; Nilius and Droogmans, 2003; Abdullaev et al., 2006) . Although less extensively studied, the efflux of K ϩ has been reported to occur via a variety of different K ϩ channels, including those gated by voltage or activated by stretch, swelling, or Ca 2ϩ (Pasantes-Morales et al., 2006) . When monitored in vitro, the efflux of both inorganic and organic osmolytes is relatively insensitive to hypo-osmotic stress, often requiring reductions in osmolarity (Ͼ30%) that are not typically encountered in vivo. However, recent studies from this and other laboratories have demonstrated that the volume-sensitive efflux of osmolytes from neural tissues can be enhanced after the activation of certain G-proteincoupled receptors (GPCRs), including the P 2Y purinergic receptors Kimelberg, 2002, 2005) , M3 muscarinic cholinergic receptors (mAChR; Loveday et al., 2003; Heacock et al., 2004) , lysophospholipid receptors (Heacock et al., 2006) , and the protease-activated-1 receptors (Cheema et al., 2005 (Cheema et al., , 2007 Ramos-Mandujano et al., 2007) . Receptor activation not only increases the extent of osmolyte release but also lowers the threshold osmolarity ("set-point") at which osmolytes are released. The latter observation raises the possibility that tonic agonist activation of cell surface receptors may permit neural cells to respond to more physiologically relevant reductions in osmolarity.
Although inorganic osmolytes are released from cultured neural cells to the same or greater extent than is observed for organic osmolytes under both basal (swelling-activated) and receptor-stimulated conditions (Abdullaev et al., 2006; Cheema et al., 2007) , chronic hyponatremia results in a disproportionately greater percentage loss of organic osmolytes than of inorganic osmolytes from the brain (Lien et al., 1991; Videen et al., 1995; Pasantes-Morales et al., 2002; Massieu et al., 2004) . One potential explanation for this observation is that, under hypo-osmotic conditions, the volume-dependent efflux of inorganic osmolytes is accompanied by a compensatory uptake phase, as previously proposed for K ϩ (Mongin et al., 1994 (Mongin et al., , 1996 . However, the issue of whether receptor activation can promote the uptake of osmolytes under hypoosmotic conditions has not, to the best of our knowledge, been previously investigated. To address this question, in the present study, we have examined the ability of mAChRs (and other GPCRs) to regulate K ϩ homeostasis in human SH-SY5Y neuroblastoma cells under conditions of hypo-osmotic stress. The results indicate that receptor activation facilitates both the efflux and influx of K ϩ in an osmosensitive manner. Under conditions of either isotonicity or limited reductions in osmolarity (15%), the efflux of K ϩ is effectively countered by an influx of K ϩ , such that no net loss of cell K ϩ occurs. Only under more pronounced reductions in osmolarity (30%) does the rate of K ϩ efflux exceed that of influx and result in a net loss of K ϩ . Thus, receptor activation serves to regulate both the release and uptake of osmolytes. A preliminary account of part of this work has appeared elsewhere (Foster et al., 2008) . Cell Culture Conditions. Human SH-SY5Y neuroblastoma cells (passages 70 -89) were grown in tissue culture flasks (75 cm 2 /250 ml) in 20 ml of DMEM supplemented with 10% (v/v) fetal calf serum with 1% penicillin/streptomycin. The osmolarity of the medium was 330 to 340 mOsM. Cells were grown at 37°C in a humidified atmosphere containing 10% CO 2 . The medium was aspirated, and cells were detached from the flask with a trypsin-versene mixture (Cambrex Bio Science). Cells were then resuspended in DMEM/10% fetal calf serum with penicillin/streptomycin and subcultured into 35-mm, six-well culture plates at a density of 250 to 300,000 cells/well for 4 to 5 days. Cells that had reached 70 to 90% confluence were routinely used.
Materials and Methods

Materials
Measurement of K ؉ Efflux. K ϩ efflux from SH-SY5Y neuroblastoma cells was determined using 86 Rb ϩ as a tracer for K ϩ . In brief, cells were prelabeled overnight to isotopic equilibrium with 19 to 37 KBq/ml 86 Rb ϩ at 37°C. After prelabeling, the cells were washed three times with 2 ml of isotonic buffer A (142 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl 2 , 3.6 mM NaHCO 3 , 1 mM MgCl 2 , 30 mM HEPES, pH 7.4, and 1 mg/ml D-glucose, ϳ340 mOsM). Cells were then allowed to incubate in 2 ml of buffer A (370 -200 mOsM; routinely rendered either hypertonic or hypotonic by an increase or decrease in NaCl concentration, respectively) in the absence or presence of agonists. In some experiments, osmolarities of the buffers were adjusted under conditions of a constant NaCl concentration (79 mM NaCl) by the addition of sucrose. Osmolarities of buffers were monitored by means of an Osmette precision osmometer (PS Precision Systems, Sudbury, MA). At the times indicated, aliquots of the extracellular medium (1 ml) were removed, and radioactivity was determined after the addition of 6 ml of Universol scintillation fluid. The reactions were terminated by rapid aspiration of the buffer, and cells were lysed by the addition of 2 ml of 0.1 M NaOH. The rate of efflux of 86 Rb ϩ was calculated as a fractional release per minute, i.e., the radioactivity released per minute into the extracellular medium as a percentage of the total radioactivity present initially in the cells. The latter was calculated as the sum of radioactivity recovered in the extracellular medium and that remaining in the lysate at the end of the assay. For all measurements, radioactivity released at the zero time point was subtracted from the observed value. Throughout the study, "basal" release of 86 Rb ϩ is defined as that which occurs at a specified osmolarity in the absence of agonists.
Measurement of K ؉ Influx. K ϩ influx was determined using 86 Rb ϩ as a tracer for K ϩ . SH-SY5Y neuroblastoma cells were washed twice with 2 ml of isotonic buffer A (ϳ340 mOsM) and then incubated in buffer A (370 -200 mOsM routinely rendered either hypertonic or hypotonic, unless otherwise stated, by an increase or decrease in NaCl concentration, respectively) containing 86 Rb ϩ (28 -56 KBq/ml) with or without agonist at 37°C. In some experiments, osmolarities of the buffers were adjusted under conditions of a constant NaCl concentration (79 mM NaCl) by the addition of sucrose. At the times indicated, the extracellular medium was aspirated, cells were washed three times with 2 ml of isotonic buffer A, and then the cells were lysed with 2 ml of 0.1 M NaOH. Aliquots of lysate (1 ml) were removed, and radioactivity was determined after the addition of 6 ml of Universol scintillation fluid. In all measurements, radioactivity accumulated at the zero time point was subtracted from the observed value. Protein contents of cell lysates were determined using a bicinchoninic acid protein assay reagent kit (Pierce Chemical, Rockford, IL) . From the measurement of 86 Rb ϩ uptake, K ϩ influx was calculated as nanomoles per milligram of protein per minute with the assumption that 86 Rb ϩ transport into the cells reflects that of K ϩ . Intracellular Water Space. The intracellular water space was measured essentially as described previously (Novak et al., 1999) . SH-SY5Y neuroblastoma cells were washed with 5 ϫ 2 ml of buffer A without D-glucose and then incubated in buffer A with increasing extracellular concentrations of 3-O-[
3 H]methyl-D-glucose at 37°C until equilibrium had been achieved (50 min). Cells were then washed with 5 ϫ 2 ml of ice-cold buffer A without glucose containing 0.1 mM phloretin and lysed with 2 ml of 0.1 M NaOH. Aliquots (1 ml) of lysate were removed, and radioactivity was determined after the addition of 6 ml of Universol scintillation fluid. Intracellular concentrations of 3-O-[
3 H]methyl-D-glucose were monitored at equilibrium, and a plot of this parameter versus the concentration of extracellular 3-O-[
3 H]methyl-D-glucose yields a line whose slope is the volume of intracellular water with respect to protein. Determination of water space by this method requires that 3-O-methyl-D-glucose not be metabolized or actively transported, and these assumptions were validated by the linearity of the plot and its extrapolation through the origin (Kletzien et al., 1975) . K ؉ Mass Measurements. SH-SY5Y cells were washed with 2 ϫ 2 ml of isotonic buffer A. Cells were then incubated for 10 min in buffer A (340 -230 mOsM rendered hypotonic by a reduction in NaCl concentration) at 37°C. The extracellular medium was then aspirated, cells were then washed with 2 ml of K ϩ free buffer A (142 mM NaCl, 2.2 mM CaCl 2 , 3.6 mM NaHCO 3 , 1 mM MgCl 2 , 30 mM HEPES, pH 7.4, and 1 mg/ml D-glucose, ϳ335 mOsM), and lysed in 2 ml of 0.1 M NaOH. Protein contents of cell lysates were determined using a bicinchoninic acid protein assay reagent kit (Pierce Chemical). Lysates from three separate 35-mm wells were combined (total volume, 6 ml) and centrifuged at 3000g for 30 min at 5°C. Supernatants were then adjusted to a final pH of between 5 and 11 with 4 N HCl. K ϩ values were obtained using a glass combination K ϩ electrode (Cole Parmer) and an Acorn Series Ion 6 meter (Oakton Instruments, Vernon Hills, IL).
Data Analysis. All experiments shown were performed in duplicate or triplicate and repeated at least three times. Values quoted are given as means Ϯ S.E.M. for the number (n) of independent experiments indicated. A two-tailed Student's t test (paired or unpaired) was used to evaluate differences between two experimental groups (level of significance, p Ͻ 0.05). Ordinary or repeated measures analysis of variance (ANOVA) followed by Dunnett's multiple comparisons test was used for statistical significance of differences between multiple groups. EC 50 values were obtained using Prism 4.0a (GraphPad Software Inc., San Diego, CA).
Results
Agonist Activation of mAChRs on SH-SY5Y Neuroblastoma Cells Enhances Both
86 Rb ؉ Influx and 86 Rb ؉ Efflux. When SH-SY5Y cells were exposed to hypotonic buffer A (230 mOsM; ϳ30% reduction in osmolarity), conditions previously determined to be optimal for the release of organic osmolytes, there was a time-dependent increase in both 86 Rb ϩ influx and 86 Rb ϩ efflux under basal conditions ("basal" is defined as influx or efflux monitored at a specified osmolarity in the absence of agonist). Inclusion of Oxo-M (100 M) elicited a marked enhancement of 86 Rb ϩ influx over basal at 3 min and thereafter and resulted in a doubling of the rate of 86 Rb ϩ uptake (Fig. 1A) . Inclusion of Oxo-M also significantly enhanced the efflux of 86 Rb ϩ in an approximately linear manner up to 10 min of incubation (rate constants for 86 Rb ϩ efflux under basal-and Oxo-M-stimulated conditions were 0.85 and 2.61%/min, respectively; Fig. 1B Because the degree of facilitation of osmolyte release observed after mAChR activation has previously been demonstrated to be dependent on the extent of hypo-osmotic stress (Loveday et al., 2003; Heacock et al., 2004) , the ability of mAChR activation to regulate 86 Rb ϩ influx and 86 Rb ϩ efflux was monitored in SH-SY5Y cells under conditions of isotonicity (340 mOsM; defined by the osmolarity of the DMEM/fetal calf serum medium in which the cells were grown), mild-to-severe hypotonicity (310 -200 mOsM), or mild hypertonicity (370 mOsM). Two experimental paradigms were used to evaluate the dependence of 86 Rb ϩ fluxes on osmolarity. In the first, buffers were rendered either hypertonic or hypotonic by increases or decreases, respectively, in the NaCl concentration (because Na ϩ and Cl Ϫ are the primary osmolytes found in plasma and reductions in plasma osmolarity observed under pathological conditions, such as hyponatremia, principally reflect changes in the concentrations of these ions). Under these conditions, the magnitude of basal 86 Rb ϩ influx was constant at all osmolarities tested. The addition of Oxo-M resulted in an increase in 86 Rb ϩ influx of ϳ75%, compared with basal, at all osmolarities (370 -200 mOsM; Fig. 3A ). In contrast, the basal efflux of 86 Rb ϩ was enhanced over that observed under isotonic conditions (340 mOsM) when osmolarity was reduced to 200 mOsM. Moreover, although the addition of Oxo-M resulted in a relatively small increase in 86 Rb ϩ efflux at both 340 and 370 mOsM, the extent of Oxo-M-stimulated 86 Rb ϩ efflux was significantly increased over isotonic at an osmolarity of 280 mOsM (a reduction in osmolarity of 18%) with a maximal enhancement observed at 230 mOsM (386% of basal; Fig. 3B ). In the second experimental paradigm, osmolar- ities of buffers were adjusted under conditions of a constant NaCl concentration (79 mM NaCl) by the addition of sucrose. Under these conditions, the basal influx of 86 Rb ϩ was significantly enhanced over that observed under isotonic conditions when the osmolarity was reduced to 230 or 200 mOsM (134 and 159% of that at 340 mOsM, respectively). The extent of Oxo-M-stimulated 86 Rb ϩ influx was also dependent upon osmolarity, and, although an increased influx was monitored under isotonic conditions, significantly greater increases were observed at 230 and 200 mOsM than at 340 mOsM (Fig. 4A) . The magnitudes of both basal-and Oxo-Mstimulated 86 Rb ϩ efflux were also found to be dependent upon the osmolarity of the buffer under conditions of a fixed concentration of NaCl, and the values obtained for 86 Rb ϩ efflux were quantitatively similar for the two experimental paradigms (Fig. 4B) . Rb ϩ influx were monitored in the absence or presence of pharmacological inhibitors at concentrations similar to those previously used (Yabaluri and Medzihradsky, 1997; Ernest et al., 2005 86 Rb ϩ release by 37 Ϯ 7 and 38 Ϯ 6%, respectively (p Ͻ 0.05; n ϭ 6 -9) and Oxo-Mstimulated 86 Rb ϩ efflux by 30 Ϯ 6 and 41 Ϯ 4%, respectively (p Ͻ 0.05; n ϭ 6 -9). The addition of specific K ϩ channel blockers such as apamin (1 M) or iberiotoxin (100 nM), inhibitors of Ca 2ϩ -activated channels, had little or no effect (Ͻ10%) on either basal or Oxo-M-stimulated 86 Rb ϩ efflux. Inclusion of glibenclamide (100 M), an inhibitor of ATPdependent K ϩ channels, had no effect on basal 86 Rb ϩ release but did result in a small, yet significant reduction in Oxo-Mstimulated 86 Rb ϩ efflux (Ͻ15% and PKC activity than that of the inorganic osmolyte, Cl Ϫ , suggesting that the release of these osmolytes may be differentially regulated (Heacock et al., 2006; Cheema et al., 2007) Rb ϩ influx over the basal value was attenuated by approximately 35% under these conditions. Inclusion of 10 M chelerythrine, a PKC inhibitor, had no effect on basal 86 Rb ϩ influx but significantly inhibited (50 -60%) the Oxo-M-stimulated component, both in the presence or absence of Ca 2ϩ /thapsigargin (Fig. 6A) Fig. 6B ). 
Influx and 86 Rb
؉ Efflux under Hypotonic Conditions. In addition to the mAChR, activation of several other GPCRs has been shown to increase the efflux of osmolytes from SH-SY5Y cells under hypotonic conditions (Heacock et al., 2006; Cheema et al., 2007) . These include the protease-activated receptor (PAR), which can be activated by thrombin and lysophospholipid receptors that can be selectively activated by either sphingosine-1-phosphate (S1P) or lysophosphatidic acid (LPA). To investigate whether activation of these receptors could also mediate changes in 86 Rb ϩ fluxes, thrombin (1.25 nM), S1P (5 M), or LPA (10 M) were added to SH-SY5Y cells under hypotonic conditions (230 mOsM), and 86 Rb ϩ influx and 86 Rb ϩ efflux were monitored after a 10-min incubation. Addition of each of the three agonists resulted in a significant increase in both 86 Rb ϩ influx and 86 Rb ϩ efflux, with a rank order of efficacy for both fluxes being thrombin ϭ S1P Ͼ Oxo-M Ͼ LPA (Fig. 7, A and B) .
Oxo-M-Mediated Regulation of Intracellular K ؉ Concentration: Roles of Osmolarity and K ؉ Influx. The ability of Oxo-M to regulate the concentration of K ϩ in SH-SY5Y cells under conditions of isotonicity (340 mOsM), mild hypotonicity (290 mOsM), or moderate hypotonicity (230 mOsM) was evaluated in the absence or presence of inhibition of K ϩ influx after a 10-min incubation. Under isotonic conditions, the intracellular K ϩ concentration, as determined by means of a K ϩ -specific electrode, was 1.22 mol K ϩ /mg protein, a value consistent with previous measurements of intracellular K ϩ in the neuroblastoma 2A cell line (ϳ1 Eq K ϩ /mg protein; Kimelberg, 1974) . Because the intracellular water space for SH-SY5Y cells was determined to be 8.5 l/mg protein (n ϭ 3), the intracellular K ϩ concentration of SH-SY5Y cells was calculated to be approximately 140 mM. Under either isotonic (340 mOsM) or mildly hypotonic (290 mOsM) conditions, the addition of Oxo-M had no significant effect on intracellular K ϩ content. However, at both osmolarities, concurrent inhibition of K ϩ influx by inclusion of furosemide (800 M) and ouabain (30 M) resulted in small but significant reductions in K ϩ mass under basal conditions (i.e., in the absence of the agonist). These reductions in K ϩ concentration were accentuated by the presence of Oxo-M (Table 1) . When cells were incubated under moderately hypotonic conditions (230 mOsM), the addition of Oxo-M resulted in a significant loss of K ϩ from the cells, even when K ϩ influx was operational. However, when K ϩ influx was prevented by inclusion of furosemide and ouabain, at this osmolarity, the addition of Oxo-M resulted in a further loss of cell K ϩ (23%) during a 10-min incubation period (Table 1) . This value for loss of K ϩ agrees closely with measurement of 86 Rb ϩ efflux under Oxo-M-stimulated conditions (rate ϭ 2.61%/min; Fig. 1B ).
Discussion
Previous studies of osmolyte loss from neural cells after their exposure to a hypo-osmotic medium have focused almost exclusively on measurement of efflux. However, the net loss of an osmolyte from a cell reflects both its release and uptake. The principal finding to emanate from the present study is that, under hypo-osmotic conditions, the activation of mAChRs in SH-SY5Y neuroblastoma cells can enhance the osmosensitive efflux and influx of 86 Rb ϩ . Furthermore, these two fluxes exhibit similar characteristics in terms of kinetics, agonist concentration dependence, and requirements for Ca 2ϩ availability and PKC activity. Because SH-SY5Y cells exhibit a relatively homogeneous population of M3 mAChRs (Ͼ80% of total; Wall et al., 1991; Slowiejko et al., 1994) , it is possible that this mAChR subtype mediates the increase in 86 Rb ϩ fluxes, as has been previously demonstrated for the osmosensitive release of taurine (Heacock et al., 2004) . In addition to the mAChR, activation of several other GPCRs that have been demonstrated previously to regulate the osmosensitive release of taurine from SH-SY5Y cells, i.e., PAR-1, S1P, and LPA receptors (Heacock et al., 2006; Cheema et al., 2007) , also promoted both the efflux and influx of 86 Rb ϩ under hypo-osmotic conditions (Fig. 7) . Furthermore, activation of PAR-1 and S1P receptors also facilitated both the influx and efflux of 86 Rb ϩ in primary cultures of rat astrocytes (data not shown). Taken collectively, these results suggest that the ability of GPCRs to regulate both the influx and efflux of 86 Rb ϩ under hypo-osmotic conditions may be a general property of neural cells. Although Oxo-M-stimulated (Fig. 5A) . These findings are consistent with previous studies in which the basal influx of 86 Rb ϩ in astrocytes and C6 glioma cells, monitored under iso-osmotic or hypo-osmotic conditions, was also inhibited by ouabain and furosemide (Kimelberg and Frangakis, 1985; Mongin et al., 1994 Mongin et al., , 1996 . KCC may also play a minor role in 86 Rb ϩ influx in SH-SY5Y cells, as previously suggested for C6 glioma (Gagnon et al., 2007) . In contrast to the results obtained for 86 Rb ϩ influx, none of the agents tested had any effect on basal 86 Rb ϩ efflux, and only the addition of either furosemide or DIOA resulted in a small inhibition (Ͻ20%) of the Oxo-M-mediated component, a result consistent with a limited involvement of KCC in 86 Rb ϩ efflux (Fig. 5B) . At least part of the 86 Rb ϩ efflux seems to be mediated by K ϩ channels because inclusion of either TEA or Ba 2ϩ attenuated both basal-and Oxo-M-stimulated efflux. However, the identity of the specific K ϩ channel(s) involved remains to be determined.
The magnitude of basal-and Oxo-M-stimulated efflux of taurine and 125 I Ϫ (used as a tracer for Cl Ϫ ) from SH-SY5Y cells is dependent upon the degree of osmotic stress, when monitored under conditions in which the buffers are rendered increasingly hypotonic by a reduction in NaCl concentration (Heacock et al., 2004; Cheema et al., 2007) . However, under the same conditions, basal-and Oxo-M-stimulated 86 Rb ϩ influx seemed to be independent of osmolarity (Fig. 3A) . Although this experimental paradigm mimics the changes encountered under physiological conditions, it also involves alterations in three experimental variables, i.e., osmolarity and the concentrations of Na ϩ and Cl Ϫ ions. When monitored under conditions in which NaCl concentration was held constant, and osmolarity varied by means of the addition of sucrose, it was evident that the magnitude of both basal-and Oxo-M-stimulated 86 Rb ϩ influx was dependent upon osmolarity (Fig. 4A ). Both basal-and Oxo-M-stimulated efflux of 86 
Rb
ϩ was found to be dependent upon the degree of osmolarity, regardless of which experimental paradigm was used (Figs. 3B and 4B) . Thus, we conclude that although 86 
ϩ efflux occurs via an osmolaritysensitive, but NaCl-independent, mechanism, 86 Rb ϩ influx is mediated by a mechanism that is dependent on both osmolarity and NaCl, consistent with the involvement of NKCC and Na Rb ϩ efflux is 6-to 7-fold (Fig. 4, A and B) .
The osmosensitive efflux of taurine and 125 I Ϫ from SH-SY5Y cells after activation of mAChRs (but not that monitored under basal conditions) is differentially regulated, with the efflux of 125 I Ϫ exhibiting less dependence on Ca 2ϩ availability and PKC activity than that observed for taurine (Cheema et a., 2007 (Fig. 6, A and B) . In contrast, both the basal influx and efflux of 86 Rb ϩ were increased by removal of Ca 2ϩ . An increase in 86 Rb ϩ efflux under Ca 2ϩ -depleted conditions has also been observed for astrocytes, although the mechanism remains unclear (Quesada et al., 1999) . Oxo-M-stimulated 86 Rb ϩ influx and efflux were also dependent on PKC activity and could be attenuated by ϳ50% after preincubation of the cells with chelerythrine. From this series of experiments, two conclusions can be drawn. First, the differential Ca 2ϩ requirements observed for basal-and mAChR-stimulated 86 Rb ϩ release provide additional support for the proposal that distinct mechanisms underlie the swelling-activated and receptor-mediated components of osmolyte release (Mongin and Kimelberg, 2005; Heacock et al., 2006 tions using a K ϩ -specific electrode. The results indicated that the addition of Oxo-M had no effect on the K ϩ content of SH-SY5Y cells when exposed to either iso-osmolarity or a mild reduction in osmolarity (290 mOsM) unless K ϩ influx was concurrently prevented by inclusion of ouabain and furosemide (Table 1 ). This result suggests that under normal conditions, the agonist stimulation of K ϩ efflux is countered by an equivalent stimulation of K ϩ influx. When monitored under more hypo-osmotic conditions (230 mOsM), Oxo-M addition results in a 10% reduction of K ϩ content, and this loss is further accentuated when K ϩ influx is prevented (23% reduction). The results obtained from measurement of K ϩ content are consistent with those derived from radiolabeling studies, which indicate that although both K ϩ influx and efflux are osmosensitive, it is the efflux pathway that is most strongly regulated by a reduction in osmolarity (Fig. 4) . Thus, although an increase in K ϩ efflux is offset by a comparable increase in K ϩ influx under conditions of limited reductions in osmolarity, when cells are incubated under more hypoosmotic conditions, the efflux of K ϩ predominates, and a net loss of K ϩ occurs. Previous studies have indicated that, under conditions of acute or chronic hyponatremia, the brain selectively retains its inorganic osmolytes (Melton et al., 1987; Pasantes-Morales et al., 2002; Massieu et al., 2004) . In the present study, we have demonstrated that activation of GPCRs not only enhances the efflux of K ϩ but also its influx. Under conditions of limited reductions in osmolarity, such as those most likely to occur under pathological conditions, the basal uptake of K ϩ , which is mediated via the NKCC and Na ϩ /K ϩ -ATPase, is markedly facilitated by receptor activation, and this permits K ϩ to be more effectively retained by the cells. These results raise the possibility that, under hyponatremic conditions, tonic receptor activity in the CNS may serve not only to enhance the efflux of osmolytes but also to maintain relatively high intracellular concentrations of K ϩ .
